ReviewJournal of Zhejiang University. Science. B2025

Future of PARP inhibitors in cancer treatment: overcoming resistance and enhancing efficacy with combination therapies.

Muhammad Shoaib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.